PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE - Patent 1144446

(19)

(11)

EP 1 144 446 A1

(12)

(43)	Date of publication:
	17.10.2001 Bulletin 2001/42

(21)	Application number: 99972641.7

(22)	Date of filing: 24.11.1999

(51)	International Patent Classification (IPC)⁷: C07K 14/18, A61K 39/29, A61P 31/20

(86)	International application number:
	PCT/EP9909/207

(87)	International publication number:
	WO 0031/129 (02.06.2000 Gazette 2000/22)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

26.11.1998 GB 9825946

(71)	Applicant: ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.
	00040 Pomezia (IT)

(72)	Inventors:
	PESSI, Antonello I-00141 Rome (IT) INGALLINELLA, Paola I-00040 Pomezia (IT) BIANCHI, Elisabetta I-00195 Rome (IT)

(74)	Representative: Thompson, John Dr. et al
	Merck & Co., Inc.European Patent DepartmentTerlings ParkEastwick Road Harlow, Essex CM20 2QR Harlow, Essex CM20 2QR (GB)

(54)	PHARMACEUTICAL COMPOUNDS FOR THE INHIBITION OF HEPATITIS C VIRUS NS3 PROTEASE